Monograph: AbobotulinumtoxinA
AHFS-Drug Information
Suche in AHFS-Drug Information
Alle Datenbanken
AbobotulinumtoxinA
Die Inhalte stehen nur registrierten Benutzern zur Verfügung.
Sie sind zum ersten mal hier und möchten die Datenbank 10-Tage kostenlos testen, dann registrieren Sie sich einmalig. Nach der Registrierung melden Sie sich mit Ihrem Benutzernamen und Passwort an.Sie sind bereits bei DrugBase registriert und möchten diese Datenbank 10-Tage kostenlos und unverbindlich testen? Dann melden Sie sich mit Ihren Zugangsdaten an und wählen Sie anschließend die Datenbank, die Sie testen möchten.
Full Title
AbobotulinumtoxinA
Generic Name
AbobotulinumtoxinA
Chemical Name
...
INV Number
...
Synonym
...
Classification
12: Autonomic Drugs
> 12:20: Skeletal Muscle Relaxants
>
12:20.92: Skeletal Muscle Relaxants, Miscellaneous
92: Pulmonary Surfactants > 92:92: Other Miscellaneous Therapeutic Agents
...
92: Pulmonary Surfactants > 92:92: Other Miscellaneous Therapeutic Agents
...
CAS Number
...
Introduction
Introduction
...
...Description
...
...Uses
Uses
...
Cervical Dystonia
...
Cosmesis of Glabellar Facial Lines
...
Spasticity
...
Upper Limb Spasticity in Adults
...
Lower Limb Spasticity in Adults
...
Lower Limb Spasticity in Pediatric Patients
...
Blepharospasm
...
...Dosage and Administration
Dosage and Administration
...
Reconstitution and Administration
...
Dosage
...
Cervical Dystonia
...
Cosmesis of Glabellar Facial Lines
...
Spasticity
...
Upper Limb Spasticity in Adults
...
Table 1: Dosing of AbobotulinumtoxinA for Upper Limb Spasticity in Adults
...
Lower Limb Spasticity in Adults
...
Table 2: Dosing of AbobotulinumtoxinA for Lower Limb Spasticity in Adults
...
Lower Limb Spasticity in Pediatric Patients
...
Table 3. Dosing of AbobotulinumtoxinA for Lower Limb Spasticity in Pediatric Patients
...
...Cautions
Cautions
...
Contraindications
...
Warnings/Precautions
...
Warnings
...
Distant Spread of Toxin Effects
...
Sensitivity Reactions
...
Hypersensitivity
...
Intradermal Sensitivity
...
Other Warnings and Precautions
...
Lack of Interchangeability Among Botulinum Toxin Preparations
...
Dysphagia/Breathing Difficulties
...
Administration Precautions in Individuals with Glabellar Facial Lines
...
Preexisting Neuromuscular Disorders
...
Risk of Viral Transmission
...
Immunogenicity
...
Reporting Adverse Effects or Overdosage
...
Specific Populations
...
Pregnancy
...
Lactation
...
Pediatric Use
...
Geriatric Use
...
Response in Various Ethnic Groups
...
Common Adverse Effects
...
...Drug Interactions
Drug Interactions
...
Anticholinergic Drugs
...
Drugs Interfering with Neuromuscular Transmission
...
Concurrent or Sequential Botulinum Toxin Treatment
...
...Advice to Patients
Advice to Patients
...
...Preparations
Preparations
...
AbobotulinumtoxinA
...
...Common general statement Elements
Additional Information
...
...References
References
...
...Copyright
AHFS® Drug Information. © Copyright, 1959-2020, Selected Revisions March 25, 2019. American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.
† Use is not currently included in the labeling approved by the US Food and Drug Administration.
Quelle
AHFS Drug Information
